A descriptive study of variables associated with obtaining nipple aspirate fluid in a cohort of non-lactating women
© Baltzell et al; licensee BioMed Central Ltd. 2006
Received: 19 May 2006
Accepted: 17 October 2006
Published: 17 October 2006
The search for biologic endpoints and biomarkers in the study of breast cancer risk assessment and risk reduction strategies has led to an interest in obtaining cytologic information and other biomarkers from nipple aspirate fluid (NAF).
This descriptive study examined factors associated with an increased ability to obtain NAF in a cohort of 3043 women between the ages of 15 and 89 years of age. The majority of women were between the ages of 30–49 (N = 1529/50.2%). Variables examined in relation to obtaining fluid include: age, marital status, age at menarche, menopausal status, a history of pregnancy, a history of breast-feeding, estrogen use, oral contraceptive use, endocrine disorders and tranquilizer use.
On average, women from whom breast fluid was obtained were younger than women from whom breast fluid was attempted but not obtained (mean = 41.9 years versus 46.5 years, p < 0.0001). In unadjusted and age-adjusted comparisons, being married, a history of pregnancy, younger age at menarche (12 years of age or younger), tranquilizer use, oral contraceptive pill (OCP) use and endocrine problems were associated with an increased ability to obtain breast fluid. Post-menopausal status and exogenous estrogen use were associated with a decreased ability to obtain breast fluid. After age-adjustment, oral contraceptive use was no longer significantly associated with an increased ability to obtain fluid and post-menopausal status was no longer associated with a decreased ability to obtain breast fluid. After multivariate adjustment, age, being married, a history of pregnancy, tranquilizer use and a history of endocrine problems remained positively associated with the ability to obtain breast fluid. In addition, menopausal women who took estrogen were less likely to yield fluid than premenopausal women.
Four variables (being married, history of pregnancy, tranquilizer use and endocrine disorders) remained positively associated with the ability to obtain NAF in all analyses. A younger age was consistently associated with a greater ability to obtain NAF in this and other studies.
The search for early stage breast cancer, or more importantly, its precursors, is the goal of many researchers hoping to reduce mortality rates from this disease. Current methods of breast cancer early detection include mammography, ultrasound, clinical breast exam (CBE) and breast self-examination (BSE). In addition to these methods, other imaging techniques such as magnetic resonance imaging (MRI) are being explored . Although these cancer detection methods have been used successfully for specific populations, biomarkers that come directly from the breast cells may add to the information obtained from the above-mentioned detection methods. One of the commonly used detection methods, mammography, appears to be less sensitive for younger women (<55 years) . Despite high suspicion of malignancy in mammography, CBE or BSE, a breast cancer diagnosis cannot be made definitively without tissue or cytologic confirmation. More importantly, concentrating on precursors of breast cancer would allow for intervention prior to the development of a malignancy. Intermediate biologic endpoints are also necessary for the evaluation of chemopreventive therapies . Recent studies have indicated that cells from nipple aspirate fluid (NAF) may yield useful information for enhancing breast cancer risk assessment . However, sensitivity has been found to be low in recent studies using other methods of breast fluid analysis for detection of breast cancer, including peri-areolar fine needle aspiration and ductal lavage [5, 6]. Determining which populations will derive the most benefit from the analysis of breast fluid requires additional study of the characteristics of the women most likely to yield fluid resulting in an accurate cytologic diagnosis. Analyzing cells in NAF is a step toward identifying tissue and/or serum based markers of breast cancer risk as 70% of women who develop breast cancer have no identifiable risks factors .
In order to utilize NAF as both an adjunct to current breast cancer risk assessment tools and/or for breast cancer early detection, it is important to understand factors influencing the obtainment of adequate fluid samples. Past studies have shown four factors consistently associated with an increased ability to obtain breast fluid; age between 35–50 years, earlier age at menarche, non-Asian compared to Asian ethnicity and a history of lactation . Using a descriptive cross-sectional design, this study examined demographic, menstrual, reproductive and other factors in relation to the ability to obtain NAF in a group of 3043 non-lactating women from the Santa Barbara, California area.
All women were volunteers seen in a private breast clinic by one physician, Dr. Otto Sartorius, who attempted NAF collection on 3413 women. The women came to the clinic for a variety of reasons and NAF was attempted as part of Dr. Sartorius's normal evaluation. The volunteers consisted of women without known breast disease, as well as private clinic patients with known or suspected breast disease . For this paper, all women with breast cancer or women who were diagnosed with breast cancer within six months of their initial clinic visit were excluded from the analysis, reducing the number of eligible subjects to 3043. Dr. Sartorius was a pioneer in the field of breast cancer research, conducting multiple studies in the area of NAF. Upon his death in 1994, Dr. Susan Love was named medical director of his research foundation. The records of Dr. Sartorius are held by The Dr. Susan Love Research Foundation, which granted access to the records to this study's first author, Kimberly Baltzell. Data regarding the obtainment of NAF and medical, reproductive and other factors were abstracted from medical records by a team led by Sandra Tillisch, R.N. in Santa Barbara, California. Human subjects approval was obtained from University of California, San Francisco (UCSF) Committee on Human Research and the UCSF Protocol Review Committee (PRC).
The nipple aspiration technique utilized on this cohort was developed by Dr. Otto Sartorius . Dr Sartorius performed all NAF attempts on this cohort for the specified time period. The aspiration device used was double-chambered. The nipples were scrubbed with 2% acetic acid to remove encrustations, and then dried before attempting aspiration. The aspiration device was placed over the nipple and negative pressure was applied with a syringe attached to the central chamber. If the central chamber was occluded, negative pressure was applied first to the outer chamber. Once fluid was observed, the aspiration device was removed and the fluid was collected in capillary tubes. This procedure was repeated until no additional fluid was expressed. Any visible or measurable quantity of NAF was considered a positive NAF sample. Volume varied from < 1 microliter to greater than 50 microliters. Past studies have shown an increase in cytologic adequacy with an increase in NAF volume .
Statistical Analysis Software (SAS)  version 8.02 was used for all statistical analyses. Distributions of variables from women for whom NAF was obtained were compared to women from whom NAF collection was attempted but not obtained using SAS procedures FREQ or UNIVARIATE and p-values were determined from chi-square and t-tests for discrete and continuous variables, respectively. Logistic regression analysis was used to estimate odds ratios for obtaining versus not obtaining fluid for variables individually adjusted for age and in a multivariate model that included age, marital status, age at menarche, pregnancy history, estrogen use, tranquilizer use and endocrine problems using SAS, PROC LOGISTIC.
Demographic, menstrual, reproductive, and other characteristics of women from the Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
Earliest Weight (lbs.)
Body Mass Index
Age at Menarche (yrs)
< 10 yrs
10 to 12 yrs
13 to 14 yrs
> 14 yrs
History of Pregnancy
Breastfed Any Child
No, but history of pregnancy
Age at Menopause (yrs)
20 to 29 yrs
30 to 39 yrs
40 to 49 yrs
50 to 59 yrs
> 59 yrs
Hysterectomy + 1 ovary
Hysterectomy + both ovaries
Both ovaries removed only
Hysterectomy, ovary unkn
External Estrogen (among menopausal women only n = 1328)
Oral Contraceptive Pills
Comparison of continuous variable mean and medians for women from whom fluid was obtained versus not obtained, Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
NAF Fluid Obtained
NAF Fluid NOT Obtained
Earliest Weight (lbs.)
Body Mass Index
Unadjusted, adjusted, and multivariate analyses of factors influencing the ability to obtain nipple aspirate fluid (NAF), Sartorius Nipple Aspirate Fluid Cohort, 1970–1990.
No NAF Obtained
Multivariate* adjusted Odds
Age at Menarche
13 and older
12 or younger
Menopausal status and Estrogen use
Menopausal and NO estrogen
Menopausal and estrogen
Oral Contraceptive Pills
This study builds on the work of Wrensch et al.  and others in illuminating factors associated with an increased ability to obtain NAF. Wrensch et al.'s work compared findings from 5 previous studies with the findings from a cohort of 1428 women. Four factors were consistently associated with NAF obtainment in the comparison: 1) age 35–55 years, 2) an earlier age at menarche, 3) non-Asian compared to Asian ethnicity and 4) history of lactation. In the present study, younger age was also found to be positively associated with obtaining fluid. This is consistent with findings by Wrensch et al. , Petrakis et al. , Petrakis et al.  and Wnyder et al. . Wrensch et al.  suggested that a decline in secretory activity of the breast may explain these findings, rather than the onset of menopause.
Although being married was positively associated in multivariate analysis with increased ability to obtain fluid in the present study, it was examined in only one other comparison study  and was not found to be significant. Marital status remained significant in all analyses in the present study, including adjustment for age and a history of pregnancy, discounting the speculation that confounding of marriage with parity and breast-feeding might explain the increased ability to obtain fluid. Given there are no ready biologic reasons to explain this finding, additional study of this variable is warranted.
A previous history of pregnancy was highly significant in the present study in all analyses and this is consistent with findings from Buehring  and Petrakis et al. . Previous studies [8, 12, 15], found an increased ability to obtain breast fluid in women with a history of lactation, although this study did not.
In the present study, postmenopausal women who used estrogen were significantly less likely to yield fluid compared with premenopausal women. Menopausal estrogen use was not found to be significant in any of the previous comparison studies [12–16] with the exception of Petrakis et al, who found that women after age 60 who used estrogen were significantly more likely to yield fluid than women who did not use estrogen over the age of 60. This is in direct contrast to the present study findings; however, this study did not differentiate estrogen users by age, only menopausal status. Given the lack of significant findings in other similar studies, it appears that exogenous estrogen use in post-menopausal women may not be an important determinant of ability to obtain breast fluid. In fact, in the present study, the inverse was found. In addition, the present study found that there were no significant differences between women who were post-menopausal and did not take estrogen and premenopausal women after adjusting for age. It seems likely that endogenous reproductive and menstrual hormones are partly responsible for the greater ability to obtain NAF in younger versus older women or in women with intact ovaries versus those with bilateral oophorectomy, given recent studies showing reduced NAF yield in women undergoing bilateral salpingo-oophorectomy (BSO), making rates of NAF production for premenopausal women undergoing BSO similar to the rates of post-menopausal women . However, at a certain age (which likely varies between women), aspects of senescence other than declining endogenous hormones also might influence breast physiology, the production of NAF, and the ability to obtain it. Greater understanding of these factors would be necessary to explain why exogenous estrogens do not appear to increase ability to obtain NAF.
Tranquilizer use was positively associated with an increased ability to yield breast fluid; however, this factor was not found to be significant in the only comparison study that considered this factor . Sartorius  suggested that some tranquilizers appear to increase breast secretions but did not formally study the effects for statistical significance. Looking at the pharmaceutical properties of tranquilizers will be necessary to further ascertain the role of this type of medication in increasing breast fluid production. The tranquilizers used during this period were probably different from tranquilizers that are used currently; therefore, these findings may not be applicable to today's women. In addition, tranquilizers may alter the protein and cellular content of NAF, affecting the fluid biology and its diagnostic value.
The endocrine disorders studied from the Sartorius cohort produced conflicting findings, given that the disorders included are diabetes and both hyper- and hypo-thyroidism. Wynder et al.  studied similar endocrine disorders but did not find any significant associations with an increased breast fluid yield.
Factors which were not found to be significantly associated with breast fluid yield in the present study which are consistent with lack of significance in other studies include menopausal status and oral contraceptive use. Only one study found oral contraceptive use to be significantly related to an increased ability to obtain breast fluid . The following significant findings in the present study; marital status, tranquilizer use and a history of endocrine disorders, have not been widely examined in other nipple aspirate fluid studies.
While the Sartorius cohort represents a unique group from which to examine important factors related to obtaining NAF, the data do have some limitations. Most notable is that in contrast to other studies, a structured questionnaire was not used to obtain information on potentially relevant factors. Instead, the data were obtained from medical record abstraction. It is possible that there may have been some inconsistency over time in how or whether factors were recorded in the medical records. Also, the cohort included women with suspected breast disease; therefore, the ability to generalize the findings may be limited. All available information regarding the characteristics of the cohort was disclosed in Table 1. Differences between studies in collection of risk factor data and characteristics of the women themselves may explain some of the inconsistencies between studies. In addition, Dr Sartorius was the sole collector of NAF in this study. Since 1990, the end point for the Sartorius study data collection, other NAF collection devices have been developed and different collection techniques have been tried. The technique mostly commonly used now includes applying warm compresses to the breast, gentle massage and the use of an aspiration cup (FirstCyte aspirator; Cytyc Corporation, Marlborough, MA) . NAF collection rates may be influenced by the device used, the technique used, as well as the person performing the NAF collection. In a 1990 meta-analysis, differences were noted in maximum pressure used, duration of pressure and definition of secretor status . All of these factors impact the percentage of successful NAF attempts reported. The quantity of the fluid present, the characteristics of the duct and nipple and the proficiency of the investigator collecting the specimen (which appears to increase after > 30 different individual NAF collections) also influence the success rates reported . Regardless of technique used, collection rates are consistently higher in younger women.
Taken together, this and other studies suggest that age is the most consistent factor affecting obtainment of breast fluid. Wrensch et al. [4, 8] obtained NAF from 42% of women less than 50 years of age. This study found NAF was obtained from roughly half of all women under 50 years, decreasing markedly after age 50 (49% and 26% respectively). Nipple aspirate fluid analysis may hold promise for younger women who do not fully benefit from current breast cancer risk assessment tools and/or breast cancer detection methods. More studies evaluating the feasibility of examining breast cells from NAF, as well as clarifying the most likely population for its use, are necessary.
Body mass index
Clinical breast exam
Magnetic resonance imaging
Nipple aspirate fluid
Oral contraceptive pills
Protocol Review Committee
Statistical Analysis Software
University of California San Francisco
This work was made possible through the cooperation of The Dr. Susan Love Research Foundation. Dr. Marylin Dodd, UCSF Department of Physiological Nursing and Dr. John Wiencke, UCSF Department of Neurological Surgery provided academic guidance to the first author throughout the project.
Funding for the study was obtained from the Department of Defense, Clinical Research Nurse Award, # DAMD17-03-1-0354.
- Hollingsworth AB, Stough R: The emerging role of breast magnetic resonance imaging. The Journal of the Oklahoma State Medical Association. 2003, 96: 299-307.PubMedGoogle Scholar
- Kolb T, Lichy J, Newhouse J: Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002, 225: 165-175.View ArticlePubMedGoogle Scholar
- Daly M, Ross E: Predicting breast cancer: the search for a model. Journal of the National Cancer Institute. 2000, 92: 1196-1197. 10.1093/jnci/92.15.1196.View ArticlePubMedGoogle Scholar
- Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M: Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. Journal of the National Cancer Institute. 2001, 93: 1791-1798. 10.1093/jnci/93.23.1791.View ArticlePubMedGoogle Scholar
- Khan SA, Wiley EL, Rodriquez N, Baird C, Ramakrishnan R, Nayar R, Bryk M, Bethke K, Staradub VL, Wolfman J, Rademaker A, Ljung BM, Morrow M: Ductal lavage findings in women with known breast cancer undergoing mastectomy. Journal of the National Cancer Institute. 2004, 96: 1510-1517.View ArticlePubMedGoogle Scholar
- Fabian CJ, Kimler BF, Mayo MS: Ductal lavage for early detection - what doesn't come out in the wash. Journal of the National Cancer Institute. 2004, 96: 1488-1489.View ArticlePubMedGoogle Scholar
- Hollingsworth AB, Nall S, Dill D: The evolution of breast cancer risk assessment. Journal of the Oklahoma State Medical Association. 2002, 95: 639-644.PubMedGoogle Scholar
- Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Research and Treatment. 1990, 15: 39-51. 10.1007/BF01811888.View ArticlePubMedGoogle Scholar
- Sartorius O, Smith H, Morris P, Benedict D, Friesen L: Cytologic evaluation of breast fluid in the detection of breast disease. Journal of the National Cancer Institute. 1977, 59: 1073-1078.PubMedGoogle Scholar
- SAS Institute: SAS Procedures Guide. 1990, Cary, N.C., SAS Institute, 6Google Scholar
- Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F: Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. Journal of the National Cancer Institute. 1975, 54: 829-834.PubMedGoogle Scholar
- Petrakis NL, Ernster VL, Sack S, King EB, Schweitzer R, Hunt T, King M: Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. Journal of the National Cancer Institute. 1981, 67: 277-284.PubMedGoogle Scholar
- Wynder E, Lahti H, Laakso K, Cheng SL, DeBevoise S, Rose D: Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer. 1985, 56: 1473-1478. 10.1002/1097-0142(19850915)56:6<1473::AID-CNCR2820560642>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
- Wynder E, Hill P, Laakso K, Littner R, Kettunen K: Breast secretion in Finnish women: A metabolic epidemiologic study. Cancer. 1981, 47: 1444-1450. 10.1002/1097-0142(19810315)47:6<1444::AID-CNCR2820470634>3.0.CO;2-A.View ArticlePubMedGoogle Scholar
- Buehring G: Screening for breast atypias using exfoliative cytology. Cancer. 1979, 43: 1788-1799. 10.1002/1097-0142(197905)43:5<1788::AID-CNCR2820430532>3.0.CO;2-Z.View ArticlePubMedGoogle Scholar
- Sharma P, Klemp JR, Simonsen M, Welsko C, Zalles CM, Kimler BF, Fabian CJ: Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Research and Treatment. 2004, 87: 59-64. 10.1023/B:BREA.0000041582.11586.d3.View ArticlePubMedGoogle Scholar
- Higgins S, Matloff E, Rimm D, Dziura J, Haffty BG, King BL: Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Research and Treatment. 2005, 7: 1017-1022.View ArticleGoogle Scholar
- Sartorius O: Breast fluid cells help in early cancer detection. Journal of the American Medical Association. 1973, 224: 823-827.Google Scholar
- Dua S, Isacke C, Gui G: The intraductal approach to breast cancer biomarker discovery. Journal of Clinical Oncology. 2006, 24: 1209-1216. 10.1200/JCO.2005.04.1830.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6874/6/15/prepub